{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T04:25:11Z","timestamp":1754195111064},"reference-count":28,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2024]]},"DOI":"10.3960\/jslrt.24007","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T22:14:55Z","timestamp":1719440095000},"page":"97-106","source":"Crossref","is-referenced-by-count":1,"title":["Atypical lymphoplasmacytic and immunoblastic proliferation: A Systematic Review"],"prefix":"10.3960","volume":"64","author":[{"given":"Midori Filiz","family":"Nishimura","sequence":"first","affiliation":[{"name":"Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Medicine, John A. Burns School of Medicine, University of Hawai\u2019i, Honolulu, HI, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Takaoka","sequence":"additional","affiliation":[{"name":"Department of Medicine, John A. Burns School of Medicine, University of Hawai\u2019i, Honolulu, HI, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharina","family":"Macapagal","sequence":"additional","affiliation":[{"name":"Department of Medicine, John A. Burns School of Medicine, University of Hawai\u2019i, Honolulu, HI, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chalothorn","family":"Wannaphut","sequence":"additional","affiliation":[{"name":"Department of Medicine, John A. Burns School of Medicine, University of Hawai\u2019i, Honolulu, HI, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asami","family":"Nishikori","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Toda","sequence":"additional","affiliation":[{"name":"Department of Pathology, Chugoku Central Hospital, Fukuyama, Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshito","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Medicine, John A. Burns School of Medicine, University of Hawai\u2019i, Honolulu, HI, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuharu","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Koo CH, Nathwani BN, Winberg CD, Hill LR, Rappaport H. Atypical lymphoplasmacytic and immunoblastic proliferation in lymph nodes of patients with autoimmune disease (autoimmune-disease-associated lymphadenopathy). Medicine (Baltimore). 1984; 63: 274-290.","DOI":"10.1097\/00005792-198409000-00002"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Kojima M, Motoori T, Matsuda H <i>et al.<\/i> Atypical lymphoplasmacytic and immunoblastic proliferation from systemic lupus erythematosus. A case report. Pathol Res Pract. 2005; 201: 531-535.","DOI":"10.1016\/j.prp.2005.05.011"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Kojima M, Motoori T, Hosomura Y <i>et al.<\/i> Atypical lymphoplasmacytic and immunoblastic proliferation from rheumatoid arthritis: a case report. Pathol Res Pract. 2006; 202: 51-54.","DOI":"10.1016\/j.prp.2005.10.005"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Sato Y, Kojima M, Takata K <i>et al.<\/i> Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman\u2019s disease. Mod Pathol. 2009; 22: 589-599.","DOI":"10.1038\/modpathol.2009.17"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Tricco AC, Lillie E, Zarin W <i>et al.<\/i> PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med. 2018; 169: 467-473.","DOI":"10.7326\/M18-0850"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 McGowan J, Straus S, Moher D <i>et al.<\/i> Reporting scoping reviews-PRISMA ScR extension. J Clin Epidemiol. 2020; 123: 177-179.","DOI":"10.1016\/j.jclinepi.2020.03.016"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Wallace ZS, Naden RP, Chari S <i>et al.<\/i> The 2019 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for IgG4\u2010Related Disease. Arthritis Rheumatol. 2020; 72: 7-19.","DOI":"10.1002\/art.41120"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Blanco R, McLaren B, Davis B, Steele P, Smith R. Systemic lupus erythematosus-associated lymphoproliferative disorder: report of a case and discussion in light of the literature. Hum Pathol. 1997; 28: 980-985.","DOI":"10.1016\/S0046-8177(97)90015-0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Kojima M, Motoori T, Nakamura S. Benign, atypical and malignant lymphoproliferative disorders in rheumatoid arthritis patients. Biomed Pharmacother. 2006; 60: 663-672.","DOI":"10.1016\/j.biopha.2006.09.004"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Kojima M, Motoori T, Asano S, Nakamura S. Histological diversity of reactive and atypical proliferative lymph node lesions in systemic lupus erythematosus patients. Pathol Res Pract. 2007; 203: 423-431.","DOI":"10.1016\/j.prp.2007.03.002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Kojima M, Nakamura N, Tsukamoto N <i>et al.<\/i> Atypical lymphoplasmacytic and immunoblastic proliferation of autoimmune disease: clinicopathologic and immunohistochemical study of 9 cases. J Clin Exp Hematop. 2010; 50: 113-119.","DOI":"10.3960\/jslrt.50.113"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Nakazato Y, Tsuchida S, Takada-Owada A <i>et al.<\/i> Castleman disease and mimickers: Clinicopathological findings of atypical lymphoproliferative disorders associated with autoimmune disease. J Clin Exp Hematop. 2022; 62: 119-126.","DOI":"10.3960\/jslrt.22025"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Kojima M, Nakamura S, Yamane Y, Tanaka H, Masawa N. Autoimmune disease-associated lymphadenopathy from dermatomyositis. A case report. Pathol Res Pract. 2003; 199: 691-694.","DOI":"10.1078\/0344-0338-00482"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Kojima M, Itoh H, Shimizu K <i>et al.<\/i> Malignant lymphoma in patients with systemic rheumatic disease (rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, and dermatomyositis): a clinicopathologic study of 24 Japanese cases. Int J Surg Pathol. 2006; 14: 43-48.","DOI":"10.1177\/106689690601400108"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Ree HJ, Kadin ME, Kikuchi M <i>et al.<\/i> Angioimmunoblastic lymphoma (AILD-type T-cell lymphoma) with hyperplastic germinal centers. Am J Surg Pathol. 1998; 22: 643-655.","DOI":"10.1097\/00000478-199806000-00001"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Attygalle AD, Kyriakou C, Dupuis J <i>et al.<\/i> Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression. Am J Surg Pathol. 2007; 31: 1077-1088.","DOI":"10.1097\/PAS.0b013e31802d68e9"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Cheuk W, Yuen HKL, Chu SYY <i>et al.<\/i> Lymphadenopathy of IgG4-related sclerosing disease. Am J Surg Pathol. 2008; 32: 671-681.","DOI":"10.1097\/PAS.0b013e318157c068"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Cree IA. The WHO Classification of Haematolymphoid Tumours. Leukemia. 2022; 36: 1701-1702.","DOI":"10.1038\/s41375-022-01625-x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Weiss LM, Jaffe ES, Liu XF <i>et al.<\/i> Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood. 1992; 79: 1789-1795.","DOI":"10.1182\/blood.V79.7.1789.1789"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg. 1996; 15: 250-257.","DOI":"10.1016\/S1085-5629(96)80038-1"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Kim DH, Koh YI. Comparison of diagnostic criteria and determination of prognostic factors for drug reaction with eosinophilia and systemic symptoms syndrome. Allergy Asthma Immunol Res. 2014; 6: 216-221.","DOI":"10.4168\/aair.2014.6.3.216"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Jeon YK, Paik JH, Park SS <i>et al.<\/i> Spectrum of lymph node pathology in adult onset Still\u2019s disease; analysis of 12 patients with one follow up biopsy. J Clin Pathol. 2004; 57: 1052-1056.","DOI":"10.1136\/jcp.2004.018010"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Kojima M, Itoh H, Hirabayashi K <i>et al.<\/i> Methtrexate-associated lymphoproliferative disorders. A clinicopathological study of 13 Japanese cases. Pathol Res Pract. 2006; 202: 679-685.","DOI":"10.1016\/j.prp.2006.05.007"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Gion Y, Iwaki N, Takata K <i>et al.<\/i> Clinicopathological analysis of methotrexate\u2010associated lymphoproliferative disorders: Comparison of diffuse large B\u2010cell lymphoma and classical Hodgkin lymphoma types. Cancer Sci. 2017; 108: 1271-1280.","DOI":"10.1111\/cas.13249"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Kojima M, Sugiura I, Itoh H <i>et al.<\/i> Histological varieties of Epstein-Barr virus-related lymph node lesion resembling autoimmune disease-like clinicopathological findings in middle-aged and elderly patients: a study of six cases. Pathol Res Pract. 2006; 202: 609-615.","DOI":"10.1016\/j.prp.2006.04.006"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Sato Y, Yoshino T. IgG4-Related Lymphadenopathy. Int J Rheumatol. 2012; 2012: 572539.","DOI":"10.1155\/2012\/572539"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Kawano Y, Noma T, Yata J. Regulation of human IgG subclass production by cytokines. IFN-gamma and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2. J Immunol. 1994; 153: 4948-4958.","DOI":"10.4049\/jimmunol.153.11.4948"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Satou A, Notohara K, Zen Y <i>et al.<\/i> Clinicopathological differential diagnosis of IgG4\u2010related disease: A historical overview and a proposal of the criteria for excluding mimickers of IgG4\u2010related disease. Pathol Int. 2020; 70: 391-402.","DOI":"10.1111\/pin.12932"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/64\/2\/64_24007\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T04:51:35Z","timestamp":1719636695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/64\/2\/64_24007\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.24007","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"24007"}}